Search Results 21-30 of 18141 for crohns disease

  1. IBD Biobank Study

    Mayo Clinic's IBD Biobank Study collects biological samples & medical information to advance research on inflammatory bowel disease, Crohn's disease & other ...

  2. Pediatric Inflammatory Bowel Disease Clinic - Mayo Clinic Children's Center

    Pediatric specialists provide cutting-edge treatment for children with ibd, including those with ulcerative colitis, Crohn's disease and other disorders.

  3. Inflammatory Bowel Disease Clinical Trials

    The management of Inflammatory Bowel Disease (IBD) is complex and time consuming. While Current Procedural Terminology for MTM services are available they are ...

  4. Crohn's Disease Clinical Trials

    Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease Rochester, MN. The purpose of this study is to assess the ...

  5. Inflammatory bowel disease (IBD) - Care at Mayo Clinic

    Chronic diarrhea and belly pain could be caused by inflammatory bowel disease. Learn about IBD causes, diagnosis and treatment.

  6. Lifestyle and Diet in Inflammatory Bowel Disease - Mayo Clinic News Network

    Inflammatory bowel disease (IBD), which consists of Crohn's disease and ulcerative colitis, can be a frustrating diagnosis to deal with. In general, there ...

  7. Mayo Clinic: Patients with Inflammatory Bowel Disease at Higher Risk for Stroke and Heart Attack

    ROCHESTER, Minn. — Oct. 14, 2013 — Patients with inflammatory bowel disease are at an increased risk of stroke and heart attack according to a new study ...

  8. Inflammatory Bowel Disease (IBD) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to better understand disease development of Irritiable Bowel Disease (IBD) and related diseases as a step to improving disease ...

  9. Inflammatory Bowel Disease Clinic - Overview

    The Inflammatory Bowel Disease Clinic diagnoses and treats inflammatory bowel diseases, including ulcerative colitis, Crohn's disease and pouchitis.

  10. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...